Articles On Memphasys (ASX:MEM)

ASX adds 52 points, hitting a new 50-day high at 8,466.70 points Broad strength with 9 of 11 sectors on the up Gold and finance stocks outperform The ASX was on a roll today, climbing swiftly in the first hour of trade and maintaining mom...

Highlights ASX 200 opens with broad sector strength led by resources and tech Eclipse Metals (ASX:EPM) surges on a significant rare earth discovery in Greenland Sunshine Metals (ASX:SHN) rallies on high-grade gold mineralisa...

US government debt was downgraded from AAA to AA1 Iron ore falls as data out of China shows weakening growth Gold climbs 0.62pc to US$3223/oz   After eight days of gains the ASX has finally stumbled, ending the day down 0.58%. It’s unlike...

ASX posts 0.22pc gains, recovering from dip earlier in the day Xero brings big profit and revenue gains in quarterly report, lifting stock 4.7pc Insurance Australia surges 5.7pc on Royal Automobile Club of Western Australia deal   It was...

US and China have slashed tariffs by 115pc Energy and Tech sectors soar 3pc ASX sets new 50-day high, up 0.43pc   Anyone betting on a backdown from the US in the US-China trade war is sitting pretty today. The US has cut its 145% tariff o...

ASX jumped 0.5pc just before midday but pared back to just 0.03pc US-China trade negotiation announcement due this evening Energy sector once again leads gains as Healthcare falls   While the first word out of the US-China trade negotiati...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10:15, once trading kicks off in earnes...

ASX wobbles into the green today, adding 13.4 points or 0.16pc Gains led by Utilities, Industrials and Tech sectors Financials worst performing sector, down 0.62pc Despite a bit of a rollercoaster of a day, the ASX has settled up just ove...

Highlights LKY’s shares surge after US rare earths project announcement, marking significant growth in the mining sector. ASX 200 sees mixed movements with cautious investor sentiment following the US Fed’s decision to maintain i...

Neuren says the number of patients discontinuing its Rett syndrome drug has fallen by two-thirds over the last year LTR Pharma launches a secondary program for swallowing disorders Telix targets throat – and other – cancers Neuren Pharmac...

A pilot study has shown that Memphasys’ (ASX: MEM) RoXsta Mega Cell high-throughput assay device can conduct large-scale, simultaneous antioxidant assays within a lab setting. The study demonstrated that the next-generation analytical platf...

Highlights Energy and uranium stocks supported market strength amid global trade discussions ASX 200 rose alongside the ASX Small Ords and ASX 200 Resources indices Standout moves from TMX, MDR, ZIP, KLS and multiple uranium...

US Secretary of the Treasury Scott Bessent is expected to meet with senior Chinese officials on Thursday Oil price hike lifts Energy sector more than 2pc Healthcare weighs on market under tariff shadow, down more than 1pc   The ASX has bu...

Highlights: Dateline Resources advances Colosseum rare earths-gold project with US listing plans Codrus Minerals prepares extensive drilling at Bull Run gold site in Oregon ASX 200 gains attention as small caps in mining and...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

ASX has gained to cinch seventh straight session in the green 10 of 11 sectors on the up Bank index lifts 1.6pc as CBA hits record new share price high The ASX is on trajectory to return to pre-trade war highs after lifting for a seventh...

Australia’s S&P/ASX 200 rallies 3.62% in April, showing resilience to global geopolitical and economic uncertainty Ten out of 11 sectors post gains in April, led by communications up 6.47% followed by a 6.37% comeback from tech DY6 Met...

Oil prices lift almost 2pc, boosting energy sector Gold reaches all-new highs of $US3,332 per ounce, pushing ASX Gold index higher Strength in rare earths lifts small cap index and materials sector   Energy and resources stocks have been...

The ASX 200 pushed into the green on a choppy Monday Fears around Trump’s tariffs trade war somewhat quelled The index was propped up by discretionary and financials sectors, as well as a couple of big miners   After a slow start, the ASX...

Memphasys (ASX: MEM) has published positive data from a pivotal clinical trial of its Felix electrophoresis-based sperm separation device for use in assisted reproduction. The trial validated the ability of the Felix device to meet and exce...

Highlights: Opthea's clinical trial results provide insights into the challenges of drug development within the biotechnology sector. Errawarra Resources strengthens its position in the mining industry through key acquisitions....

The ASX has been trading flat at around 7,928 points. Discretionary has been the best performing sector today, up 1%, followed by Financials, up 0.66%, and Utilities, up 0.5%. Staples has been the worst performing, down 1%, followed b...

Reproductive technology developed by Memphasys (ASX:MEM) is proving to be a gamechanger in addressing the men’s side of infertility – which is now understood to cause at least half of all conception issues. The company’s Felix™ System ha...

The S&P/ASX 200 Health Care Index fell 7.66% in February with the S&P/ASX 200 down 3.79% Morgans healthcare analyst Iain Wilkie said several factors caused investor jitters in February including job cuts to US FDA  Pacific Edge was...

ASX drops on tariff fears; BHP, Rio hit Star Entertainment Group sinks amid financial crisis Life360 shines as Endeavour tanks   It was a rough day for the ASX, dropping 1.16% as fears over new US-China tariffs sent Aussie stocks spiralli...

ASX hovers near one-month low, dragged by GYG and banks Domain soars on takeover bid RBA’s bullock admits slow rate hikes, while Alibaba rebounds   The ASX had a rough afternoon on Friday, with the market closing near its one-month low. D...

Pro Medicus signs $33m deal with University of Kentucky Memphasys’ RoXsta system advances antioxidant profiling potential Acrux launches 90-gram Dapsone Gel in US   These are today’s healthcare announcements from the ASX, with major progr...

Memphasys Ltd (ASX:MEM) has seen a boost to its proprietary antioxidant profiling system RoXsta through the publication of a recent manuscript that emphasises its commercial potential and scientific credibility. The publication, ‘A Compa...

The S&P/ASX 200 Health Care Index fell 1.85% in December but rose 7.51% overall in 2024  Mesoblast surged 52% in December after the US FDA approved its cell therapy Ryoncil for treatment of paediatric GvHD Percheron plunged 91% in Dece...

The S&P/ASX 200 fell 3% in December as Santa rally failed to eventuate yet again  Consumer staples led the S&P/ASX 200 sectors in December with tech leading overall in 2024 Niobium and rare earths explorer Aldoro Resources led the...

The ASX has renewed its Santa rally closing with strong gains  Financials/banks raked it in, on the whole, with all sectors in the green News Corp’s blockbuster Foxtel deal with DAZN turned heads; Bitcoin… meh   Investors have seemingly b...

Biotech nanocap Memphasys (ASX:MEM) has sent a demo unit of its Felix sperm separator system to a hospital in Dubai, United Arab Emirates. In short, to make artificial insemination work, you need to separate the actual sperm from semen,...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

The S&P/ASX 200 rose 4% in November to a new record high of 8436.23 points as volatility fell following US election Information Technology led the gainers rising 10% in November and remained top performer YTD, up 56.79%  NoviqTech rose...

ASX rises on rally across the board Israel and Hezbollah agree to 60-day ceasefire City Chic tumbles after downbeat update   The Aussie share market enjoyed a solid ride on Wednesday, driven by a broad rally as optimism from Wall Street’s...

ASX drops as Trump’s tariff threat rattles markets Bluescope and Reece rise amid energy and bank sell-off EML Payments jumps after strong earnings report   The ASX closed in the red on Tuesday, down by 0.45% after being dragged down by a...

ASX up as mining gains offset tech and bank losses Silex, Paladin and uranium stocks soar on supply squeeze Goldman cuts Aussie GDP forecast as US tariffs loom   After a soft start to the day, the ASX bounced back and closed the day 0.3% ...

ASX up, Xero leads gains Miners hit as iron ore drops, Variscan jumps 50pc Asian stocks down, Bitcoin hits US$93k before retreating   Aussie shares climbed higher on Thursday, powered by a rally in tech companies and the big banks. At the...

ASX slipped after early gains, then finished strongly  Energy sector helped offset losses; Quickstep, Sigma Healthcare turned heads Wall Street rallied to record highs after Trump’s win   The ASX swung from gains, to losses at lunchtime,...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

  ASX slips  as US jobs data fuels Wall Street panic Westpac gets a new CEO Newcomers into the ASX200 index include Guzman u Gomez   The ASX stumbled by 0.3% on Monday after the US jobs report fell short on Friday night, causing Wall Str...

Lumos Diagnostics to raise $10 million, with a little help from an iron-ore baron Memphasys is not horsing around as it trials its Felix sperm-separation device for the equine market Medical cannabis and telehealth play Vitura Health says...

ASX likely to fall sharply after Nvidia’s 9.5pc drop Alphabet, Microsoft, and Apple all also took major hits Weak manufacturing data and falling oil prices are heightening fears   The ASX is likely to drop sharply on Wednesday after Nvidi...

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

S&P/ASX 200 had its best month of the year in July finishing up 4% to record high S&P Dow Jones Indices says large cap companies continued to lead the market in July Consumer discretionary and real estate topped July sector leaders...

ASX rises on Thursday Nine sectors end higher, led by property stocks Small caps led by BEZ   The local benchmark index hit a record high this morning before trimming gains late. The S&P/ASX200 closed up Thursday, gaining 22.40 poi...

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

ASX rises on Monday after Wall Street banked a belter on Friday All 11 local sectors higher, InfoTech winning the race for Best in Show Aruma Resources led the small caps winners   The local benchmark moved strongly into positive terri...